Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.00041 | 1 |